InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,290.11
(
-0.13%
)
US TECH 100
18,050.00
(
-0.16%
)
Dow Jones
39,895.65
(
0.07%
)
Brent Oil
83.77
(
0.67%
)
Bitcoin
66,479.24
(
1.90%
)
Post# of 459294
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

sokol

Send PM Follow Ignore
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

sokol

Re: falconer66a post# 143528

Monday, 03/05/2018 7:18:52 PM

Monday, March 05, 2018 7:18:52 PM

Post# of 459294
It may be that during the drug approval process Anavex will attempt to obtain approval for a label that may broadly cover seizures to result in AVXl 2-73 being covered by insurance for CNS diseases involving seizures.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM

VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM

ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM

Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM

Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM

HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!